{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:27:39Z","timestamp":1793978859877,"version":"4.8.0"},"reference-count":11,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,12]]},"abstract":"<jats:sec>\n                    <jats:title>Background:<\/jats:title>\n                    <jats:p>Vancomycin (VCM)-associated acute kidney injury is a clinically important adverse event. Appropriate dose adjustment requires knowledge of factors influencing VCM clearance; however, these factors remain poorly characterized in pediatric patients. We report a pediatric case in which elevated blood VCM concentrations seemed to be associated with an increased arginine vasopressin (AVP) infusion rate.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Case presentation:<\/jats:title>\n                    <jats:p>\n                      A 9-month-old female infant (6.9 kg, 64 cm) underwent craniotomy for hematoma removal after a traumatic fall. Postoperatively, a surgical site infection was suspected, and VCM was initiated at 90 mg every 6 hours. Initial therapeutic drug monitoring (TDM) showed a trough concentration (C\n                      <jats:sub>trough<\/jats:sub>\n                      ) of 6.3 mcg\/mL, below therapeutic range for pediatric patients. The VCM dose was increased to 140 mg every 6 hours. Repeat TDM showed a C\n                      <jats:sub>trough<\/jats:sub>\n                      of 19.0 mcg\/mL. Before VCM initiation, the patient was administered continuous AVP infusion for central diabetes insipidus (CDI) associated with trauma. During VCM therapy, the AVP infusion rate was increased from 0.6 to 1.0 mL\/h because of increased urine output, but urine output remained unchanged. After the elevated C\n                      <jats:sub>trough<\/jats:sub>\n                      , the VCM dose was reduced to 90 mg every 6 hours, whereas the AVP infusion rate was increased further to 3.2 mL\/h. TDM performed before the fourth dose after dose reduction showed a C\n                      <jats:sub>trough<\/jats:sub>\n                      of 10.5 mcg\/mL, approximately twice the initial concentration despite the same VCM dosage.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions:<\/jats:title>\n                    <jats:p>Increased AVP infusion may have reduced the glomerular filtration rate and elevated the blood VCM concentration, independent of urine output. To our knowledge, this is the first pediatric case reporting elevated blood VCM concentrations associated with an increased AVP infusion rate despite persistent urine output in a patient with CDI. Clinicians should be aware that changes in AVP infusion rates may influence VCM exposure, and closer TDM may be warranted when AVP doses are adjusted.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ftd.0000000000001523","type":"journal-article","created":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T14:00:26Z","timestamp":1792159226000},"page":"717-722","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Effect of Vasopressin Infusion Rate on Vancomycin Dose Adjustment in Pediatric Central Diabetes Insipidus: Grand Round\/A Case Study"],"prefix":"10.1097","volume":"48","author":[{"given":"Hiroyuki","family":"Ono","sequence":"first","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7616-4990","authenticated-orcid":false,"given":"Sho","family":"Tashiro","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Tanaka","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nao","family":"Kohri","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oita University School of Medicine, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryosuke","family":"Tatsuta","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hironori","family":"Goto","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oita University School of Medicine, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Ohchi","sequence":"additional","affiliation":[{"name":"Department of Anesthesiology and Intensive Care, Faculty of Medicine, Oita University, Yufu, Oita, Japan; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukari","family":"Kawasaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medicine, Oita University, Yufu, Oita, Japan."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Ihara","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Oita University School of Medicine, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Itoh","sequence":"additional","affiliation":[{"name":"Department of Clinical Pharmacy, Oita University Hospital, Yufu, Oita, Japan;"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,10,16]]},"reference":[{"key":"R1-20261106","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s10157-021-02165-x","article-title":"Validation of the estimated glomerular filtration rate equation for Japanese children younger than 2 years","volume":"26","author":"Gotoh","year":"2022","journal-title":"Clin Exp Nephrol"},{"key":"R3-20261106","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.jiac.2023.10.025","article-title":"Cohort study of the risk factors and the target AUC to avoid vancomycin-associated acute kidney injury in pediatric patients","volume":"30","author":"Kanazawa","year":"2024","journal-title":"J Infect Chemother"},{"key":"R4-20261106","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3390\/antibiotics14060570","article-title":"Impact of recovery from febrile neutropenia on intra-individual variability in vancomycin pharmacokinetics in pediatric patients","volume":"14","author":"Takumi","year":"2025","journal-title":"Antibiotics (Basel)"},{"key":"R5-20261106","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s13318-021-00730-z","article-title":"Pharmacokinteics of vancomycin in critically ill children: a systematic review","volume":"47","author":"Akunne","year":"2022","journal-title":"Eur J Drug Metab Pharmacokinet"},{"key":"R6-20261106","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/ki.1996.101","article-title":"Vasodilation induced by vasopressin V2 receptor stimulation in afferent arterioles","volume":"49","author":"Tamaki","year":"1996","journal-title":"Kidney Int"},{"key":"R7-20261106","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/j.1365-201X.2004.01352.x","article-title":"The effect of AVP-V receptor stimulation on local GFR in the rat kidney","volume":"182","author":"Roald","year":"2004","journal-title":"Acta Physiol Scand"},{"key":"R8-20261106","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1152\/japplphysiol.00825.2006","article-title":"Vasopressin-induced vasoconstriction: two concentration-dependent signaling pathways","volume":"102","author":"Henderson","year":"1985","journal-title":"J Appl Physiol"},{"key":"R9-20261106","doi-asserted-by":"crossref","first-page":"223S","DOI":"10.1111\/j.1469-445X.2000.tb00027.x","article-title":"Control of the renal medullary circulation by vasopressin V1 and V2 receptors in the rat","volume":"85","author":"Cowley","year":"2000","journal-title":"Exp Physiol"},{"key":"R10-20261106","first-page":"1","article-title":"High concentration of vancomycin in children with central diabetes insipidus: a retrospective case series","volume":"10","author":"Ochi","year":"2020","journal-title":"Pediatr Therapeut"},{"key":"R12-20261106","doi-asserted-by":"crossref","first-page":"2932","DOI":"10.1093\/jac\/dkab302","article-title":"Population pharmacokinetics of vancomycin in paediatric patients with febrile neutropenia and augmented renal clearance: development of new dosing recommendations","volume":"76","author":"Shimamoto","year":"2021","journal-title":"J Antimicrob Chemother"},{"key":"R13-20261106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2174\/1570159X17666190717150501","article-title":"Vasopressin & oxytocin in control of the cardiovascular system: an updated review","volume":"18","author":"Japundzic-Zigon","year":"2020","journal-title":"Curr Neuropharmacol"}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001523","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T15:01:22Z","timestamp":1793977282000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/FTD.0000000000001523"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,16]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000001523","relation":{},"ISSN":["0163-4356","1536-3694"],"issn-type":[{"value":"0163-4356","type":"print"},{"value":"1536-3694","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,16]]},"assertion":[{"value":"2026-03-16","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-07-20","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}